| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.05 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.06 | 0.05 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.06 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |